TEVA - Teva Pharmaceutical Industries Limited

...

Available for logged in users only.

The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.

• Biggest stock movers today: Plug Power, Paramount Global, Google parent Alphabet, and more
• Teva Pharmaceutical Non-GAAP EPS of $1.00 beats by $0.24, revenue of $4.46B beats by $450M
• Teva to divest API unit to focus on core business strengths
• Teva earnings preview: Israeli drugmaker to report early Wednesday
• PBMs ramp up lobbying efforts amid growing public scrutiny
• Watch GSK amid evidence hearing on Zantac litigation
• Teva raised to Buy at Jefferies citing a positive setup ahead of 2024 outlook
• GSK, Teva, AstraZeneca under Senate probe over asthma inhaler pricing
• J.P. Morgan event in spotlight as biotech M&A, obesity frenzy, AI pick up
• Piper Sandler raises Teva to neutral, stock up 4%
• Bank of America more favorable on SMID-cap biotechs into 2024
• Corcept Therapeutics plunges after loss in patent battle with Teva
• Europe revokes approvals for generics of Biogen's multiple sclerosis drug Tecfidera
• AbbVie, AstraZeneca targeted for improper use of drug patents
• AbbVie, Amgen among firms targeted for latest Medicare inflation penalties
• Teva analysis shows migraine drug as effective in obese patients as non-obese
• Purdue Pharma bankruptcy settlement heads to Supreme Court review
• Teva raised to Buy at UBS on brand transition
• Teva gains U.S. approval for generic version of osteoporosis injection
• Teva inks $125M deal with Royalty Pharma to develop antipsychotic drug